Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
J M Carethers, … , M Koi, C R Boland
J M Carethers, … , M Koi, C R Boland
Published July 1, 1996
Citation Information: J Clin Invest. 1996;98(1):199-206. https://doi.org/10.1172/JCI118767.
View: Text | PDF
Research Article

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

  • Text
  • PDF
Abstract

The phenomenon of alkylation tolerance has been observed in cells that are deficient in some component of the DNA mismatch repair (MMR) system. An alkylation-induced cell cycle arrest had been reported previously in one MMR-proficient cell line, whereas a MMR-defective clone derived from this line escapes from this arrest. We examined human cancer cell lines to determine if the cell cycle arrest were dependent upon the MMR system. Growth characteristics and cell cycle analysis after MNNG treatment were ascertained in seven MMR-deficient and proficient cell lines, with and without confirmed mutations in hMLH1 or hMSH2 by an in vitro transcription/translation assay. MMR-proficient cells underwent growth arrest in the G2 phase of the cell cycle after the first S phase, whereas MMR-deficient cells escaped an initial G2 delay and resumed a normal growth pattern. In the HCT116 line corrected for defective MMR by chromosome 3 transfer, the G2 phase arrest lasted more than five days. In another MMR-proficient colon cancer cell line, SW480, cell death occurred five days after MNNG treatment. A competent MMR system appears to be necessary for G2 arrest or cell death after alkylation damage, and this cell cycle checkpoint may allow the cell to repair damaged DNA, or prevent the replication of mutated DNA by prohibiting clonal expansion.

Authors

J M Carethers, M T Hawn, D P Chauhan, M C Luce, G Marra, M Koi, C R Boland

×

Total citations by year

Year: 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1992 Total
Citations: 1 1 3 4 2 3 4 4 3 5 3 4 5 7 4 3 8 1 9 3 4 6 5 13 9 3 1 118
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (118)

Title and authors Publication Year
Serendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy.
Boland CR, Koi M, Hawn MT, Carethers JM, Yurgelun MB
Digestive Diseases and Sciences 2023
Lynch Syndrome - a mechanistic and clinical management update
Curtius K, Gupta S, Boland CR
Alimentary Pharmacology & Therapeutics 2022
Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels
MÖ Raeker, J Pierre-Charles, JM Carethers
CMGH Cellular and Molecular Gastroenterology and Hepatology 2020
Aspirin and the chemoprevention of cancers: A mathematical and evolutionary dynamics perspective
NL Komarova, CR Boland, A Goel, D Wodarz
Wiley interdisciplinary reviews. Systems biology and medicine 2020
Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer.
Raeker MO, Carethers JM
Journal of cancer immunology 2020
Exploiting DNA repair defects in colorectal cancer
NM Reilly, L Novara, FD Nicolantonio, A Bardelli
Molecular Oncology 2019
Efforts in redesigning the antileukemic drug 6-thiopurine: decreasing toxic side effects while maintaining efficacy
AX Hernandez, CJ Weeramange, P Desman, A Fatino, O Haney, RJ Rafferty
MedChemComm 2019
New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators
C Weeramange, A Lansakara, J Dallman, T Nguyen, W Hulangamuwa, RJ Rafferty
MedChemComm 2019
Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome
D Bouvet, S Bodo, A Munier, E Guillerm, R Bertrand, C Colas, A Duval, F Coulet, M Muleris
Gastroenterology 2019
Recent progress in Lynch syndrome and other familial colorectal cancer syndromes: Familial Colorectal Cancer
PM Boland, MB Yurgelun, CR Boland
CA: a cancer journal for clinicians 2018
Inhibition of UDP-glucose dehydrogenase by 6-thiopurine and its oxidative metabolites: Possible mechanism for its interaction within the bilirubin excretion pathway and 6TP associated liver toxicity
CJ Weeramange, CM Binns, C Chen, RJ Rafferty
Journal of Pharmaceutical and Biomedical Analysis 2018
HEREDITARY, SPORADIC AND METASTATIC COLORECTAL CANCER ARE COMMONLY DRIVEN BY SPECIFIC SPECTRUMS OF DEFECTIVE DNA MISMATCH REPAIR COMPONENTS
John M Carethers
Transactions of the American Clinical and Climatological Association 2017
The colorectal cancer immune microenvironment and approach to immunotherapies
M Koi, JM Carethers
Future Oncology 2017
Methylation and expression of mismatch repair gene human mutS homolog 2 in myelodysplastic syndromes
X Liu, S Liu, J Lei, L Zou, L Xiao, G Zhang
Experimental and therapeutic medicine 2017
GRG Profiles: John M. Carethers
JM Carethers
Digestive Diseases and Sciences 2016
Chemotherapeutic implications in microsatellite unstable colorectal cancer1
Won-Seok Jo, John M. Carethers
Cancer biomarkers : section A of Disease markers 2016
Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
CM Zhang, JF Lv, L Gong, LY Yu, XP Chen, HH Zhou, L Fan
International journal of environmental research and public health 2016
Human MLH1 suppresses the insertion of telomeric sequences at intra-chromosomal sites in telomerase-expressing cells
P Jia, M Chastain, Y Zou, C Her, W Chai
Nucleic Acids Research 2016
Diagnosis of Constitutional Mismatch Repair-deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents
S Bodo, C Colas, O Buhard, A Collura, J Tinat, N Lavoine, A Guilloux, A Chalastanis, P Lafitte, F Coulet, MP Buisine, D Ilencikova, C Ruiz-Ponte, M Kinzel, S Grandjouan, H Brems, S Lejeune, H Blanché, Q Wang, O Caron, O Cabaret, M Svrcek, D Vidaud, B Parfait, A Verloes, UJ Knappe, F Soubrier, I Mortemousque, A Leis, J Auclair-Perrossier, T Frébourg, JF Fléjou, N Entz-Werle, J Leclerc, D Malka, O Cohen-Haguenauer, Y Goldberg, AM Gerdes, F Fedhila, M Mathieu-Dramard, R Hamelin, B Wafaa, M Gauthier-Villars, F Bourdeaut, E Sheridan, H Vasen, L Brugières, K Wimmer, M Muleris, A Duval
Gastroenterology 2015
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
JM Carethers
World journal of gastroenterology : WJG 2015
A Monofunctional Platinum Complex Coordinated to a Rhodium Metalloinsertor Selectively Binds Mismatched DNA in the Minor Groove
AG Weidmann, JK Barton
Inorganic Chemistry 2015
Distinctive Tumor Biology of MSI-High Colorectal Cancer
N Majithia, BR Kipp, A Grothey
Current Colorectal Cancer Reports 2015
Inter-individual variation in DNA repair capacity: A need for multi-pathway functional assays to promote translational DNA repair research
ZD Nagel, IA Chaim, LD Samson
DNA repair 2014
Targeted Chemotherapy with Metal Complexes
AG Weidmann, AC Komor, JK Barton
COMMENT INORG CHEM 2014
An Unusual Ligand Coordination Gives Rise to a New Family of Rhodium Metalloinsertors with Improved Selectivity and Potency
AC Komor, JK Barton
Journal of the American Chemical Society 2014
Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study
LH Jensen, AA Rasmussen, L Byriel, H Kuramochi, DG Crüger, J Lindebjerg, PV Danenberg, A Jakobsen, K Danenberg
Cellular Oncology 2013
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio
Emery and Rimoin's Principles and Practice of Medical Genetics 2013
Development and Characterization of a Non-Natural Nucleoside that Displays Anti-Cancer Activity Against Solid Tumors
J Golden, E Motea, X Zhang, JS Choi, Y Feng, Y Xu, I Lee, AJ Berdis
ACS chemical biology 2013
The path for metal complexes to a DNA target
AC Komor, JK Barton
Chemical Communications 2013
The History of Lynch Syndrome
CR Boland, HT Lynch
Familial Cancer 2013
Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colorectal Cancer
JM Carethers
Journal of Gastrointestinal Surgery 2012
Cell-Selective Biological Activity of Rhodium Metalloinsertors Correlates with Subcellular Localization
AC Komor, CJ Schneider, AG Weidmann, JK Barton
Journal of the American Chemical Society 2012
How Is the Formation of Comet Tails Supported by the Incision Step of Nucleotide Excision Repair?
C Odajima, T Nakamura, M Nakai, K Yamazaki, S Hattori, N Murakami, G Honda, A Yamamoto, S Kawaguchi, YF Sasaki
Genes and Environment 2012
Microsatellite instability in the management of colorectal cancer
MS Pino, DC Chung
Expert Review of Gastroenterology & Hepatology 2011
Involvement of mismatch repair proteins in adaptive responses induced by N-methyl-N′-nitro-N-nitrosoguanidine against γ-induced genotoxicity in human cells
A Yamamoto, Y Sakamoto, K Masumura, M Honma, T Nohmi
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011
Selective Cytotoxicity of Rhodium Metalloinsertors in Mismatch Repair-Deficient Cells
RJ Ernst, AC Komor, JK Barton
Biochemistry 2011
N -Methyl- N ′-nitro- N -nitrosoguanidine (MNNG) Triggers MSH2 and Cdt2 Protein-dependent Degradation of the Cell Cycle and Mismatch Repair (MMR) Inhibitor Protein p21 Waf1/Cip1
T Jascur, R Fotedar, S Greene, E Hotchkiss, CR Boland
The Journal of biological chemistry 2011
Microsatellite Instability in Colorectal Cancer
CR Boland, A Goel
Gastroenterology 2010
A knockout for Lynch syndrome
CR Boland
Gastroenterology 2010
DNA mismatch repair and the DNA damage response to ionizing radiation: Making sense of apparently conflicting data
LM Martin, B Marples, M Coffey, M Lawler, TH Lynch, D Hollywood, L Marignol
Cancer Treatment Reviews 2010
Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner
H Chung, J Chaudhry, CG Lopez, JM Carethers
Cancer biology & therapy 2010
Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma
G Hall, A Clarkson, A Shi, E Langford, H Leung, RP Eckstein, AJ Gill
Pathology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
HT Lynch, PM Lynch, SJ Lanspa, CL Snyder, JF Lynch, CR Boland
Clinical Genetics 2009
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management
HT Lynch, MJ Casey, CL Snyder, C Bewtra, JF Lynch, M Butts, AK Godwin
Molecular Oncology 2009
MLH1 deficiency enhances tumor cell sensitivity to ganciclovir
JJ O'Konek, PD Boucher, AA Iacco, TE Wilson, DS Shewach
Cancer Gene Therapy 2009
DNA mismatch binding and antiproliferative activity of rhodium metalloinsertors
RJ Ernst, H Song, JK Barton
Journal of the American Chemical Society 2009
Simulated microgravity decreases DNA repair capacity and induces DNA damage in human lymphocytes
R Kumari, KP Singh, JW DuMond
Journal of Cellular Biochemistry 2009
Colorectal Cancer Due to Deficiency in DNA Mismatch Repair Function
AM Bellizzi, WL Frankel
Advances in Anatomic Pathology 2009
Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
C Campregher, MG Luciani, C Gasche
Gut 2008
Genomic and epigenetic instability in colorectal cancer pathogenesis
WM Grady, JM Carethers
Gastroenterology 2008
Review: Systemic treatment of advanced colorectal cancer: Tailoring therapy to the tumor
JM Carethers
Therapeutic advances in gastroenterology 2008
Intestinal Inflammation and Colorectal Cancer
C Gasche, JM Gutiérrez, M Gassull, E Monterio
2008
The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside
CR Boland, M Koi, DK Chang, JM Carethers
Familial Cancer 2007
DNA repair in mammalian embryos
S Jaroudi, S SenGupta
Mutation Research/Reviews in Mutation Research 2007
Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge
CR Boland
Journal of Clinical Oncology 2007
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
J Warusavitarne, M Schnitzler
International Journal of Colorectal Disease 2006
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer
JM Carethers
Gut 2006
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer
C Lamberti, S Lundin, M Bogdanow, C Pagenstecher, N Friedrichs, R Büttner, T Sauerbruch
International Journal of Colorectal Disease 2006
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications
HT Lynch, CR Boland, G Gong, TG Shaw, PM Lynch, R Fodde, JF Lynch, A la Chapelle
European Journal of Human Genetics 2006
Structure and function of the components of the human DNA mismatch repair system
T Jascur, CR Boland
International Journal of Cancer 2006
Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art
AM Valentini, R Armentano, M Pirrelli, ML Caruso
Cancer Treatment Reviews 2006
Chemotherapeutic implications in microsatellite unstable colorectal cancer
Won-Seok Jo, John M Carethers
Cancer biomarkers : section A of Disease markers 2006
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients
G Lanza, R Gafà, A Santini, I Maestri, L Guerzoni, L Cavazzini
Journal of Clinical Oncology 2006
Signalling cell cycle arrest and cell death through the MMR System
V O'Brien, R Brown
Carcinogenesis 2005
The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance
A Tajima, MT Hess, BL Cabrera, RD Kolodner, JM Carethers
Gastroenterology 2004
Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts
CR Boland
Proceedings (Baylor University. Medical Center) 2004
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
JM Carethers, EJ Smith, CA Behling, L Nguyen, A Tajima, RT Doctolero, BL Cabrera, A Goel, CA Arnold, K Miyai, CR Boland
Gastroenterology 2004
Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines
Y Yao, H Tao, JJ Kim, B Burkhead, E Carloni, A Gasbarrini, AR Sepulveda
Laboratory Investigation 2004
Induction of apoptosis and G2/M arrest by N-methyl-N′-nitro-N-nitrosoguanidine in human prostate carcinoma cells
C Park, BT Choi, JH Cheong, SK Moon, CH Kim, WH Lee, YH Choi
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2004
Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damage
A Lützen, HC Bisgaard, LJ Rasmussen
Experimental Cell Research 2004
Clement Richard Boland, Jr., MD: A Conversation with the Editor
CR Boland
Proceedings (Baylor University. Medical Center) 2004
Mismatch repair and DNA damage signalling
L Stojic, R Brun, J Jiricny
DNA repair 2004
Molecular Genetics of Colorectal Neoplasia
J Church, G Casey
2004
DNA Repair Enzymes and Cytotoxic Effects of Temozolomide: Comparative Studies Between Tumor Cells and Normal Cells of the Immune System
E Pagani, R Pepponi, MP Fuggetta, SP Prete, M Turriziani, L Bonmassar, PM Lacal, S Falcinelli, F Passarelli, F Guadagni, E Alvino, S D'atri
Journal of chemotherapy (Florence, Italy) 2003
Value of Histopathology in Predicting Microsatellite Instability in Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal Cancer:
J Shia, NA Ellis, PB Paty, GM Nash, J Qin, K Offit, XM Zhang, AJ Markowitz, K Nafa, JG Guillem, WD Wong, WL Gerald, DS Klimstra
The American Journal of Surgical Pathology 2003
A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage
M Meyers, A Hwang, MW Wagner, AJ Bruening, ML Veigl, WD Sedwick, DA Boothman
Oncogene 2003
SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression
AS Jaiswal, S Narayan
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2002
Lack of Benefit of 5-Fluorouracil-Based Adjuvant Chemotherapy in Colorectal Cancer with Microsatellite Instability
L Johnson, E Chu
Clinical Colorectal Cancer 2002
Cellular effects of CPT-11 on colon carcinoma cells: Dependence on p53 and hMLH1 status: Genetic Determinants of Chemosensitivity
R Magrini, MR Bhonde, ML Hanski, M Notter, H Scherübl, CR Boland, M Zeitz, C Hanski
International Journal of Cancer 2002
Identification of Transdominant-Negative Genetic Suppressor Elements Derived from hMSH2 That Mediate Resistance to 6-Thioguanine
MM de las Alas, G Los, X Lin, B Kurdi-Haidar, G Manorek, SB Howell
Molecular pharmacology 2002
Diagnosis of microsatellite instability-positive colorectal cancer
P Starostik, HK Müller-Hermelink
Expert Review of Molecular Diagnostics 2001
Growth inhibition due to complementation oftransforming growth factor-? receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells
Y Miyafuji, X Zhong, I Uchida, M Koi, H Hemmi
Journal of Cellular Physiology 2001
The Deprivation Syndrome is the Driving Force of Phylogeny, Ontogeny and Oncogeny
K Heininger
Reviews in the Neurosciences 2001
Different effects of methotrexate on DNA mismatch repair proficient and deficient cells
I Frouin, E Prosperi, M Denegri, C Negri, M Donzelli, L Rossi, F Riva, M Stefanini, AI Scovassi
European Journal of Cancer 2001
Mechanisms of tolerance to DNA damaging therapeutic drugs
P Karran
Carcinogenesis 2001
Mismatch repair in correction of replication errors and processing of DNA damage
G Aquilina, M Bignami
Journal of Cellular Physiology 2001
Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer
Y Watanabe, A Haugen-Strano, A Umar, K Yamada, H Hemmi, Y Kikuchi, S Takano, Y Shibata, JC Barrett, TA Kunkel, M Koi
Molecular Carcinogenesis 2000
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
DC Chung
Gastroenterology 2000
The Human Cyclin B1 Protein Modulates Sensitivity of DNA Mismatch Repair Deficient Prostate Cancer Cell Lines to Alkylating Agents
LJ Rasmussen, M Rasmussen, A Lützen, HC Bisgaard, KK Singh
Experimental Cell Research 2000
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability
SM Lipkin, V Wang, R Jacoby, S Banerjee-Basu, AD Baxevanis, HT Lynch, RM Elliott, FS Collins
Nature Genetics 2000
The Absence of Msh2 Alters Abelson Virus Pre-B-Cell Transformation by Influencing p53 Mutation
J Jenab-Wolcott, D Rodriguez-Correa, AH Reitmair, T Mak, N Rosenberg
Molecular and cellular biology 2000
The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations
P Hausner, DJ Venzon, L Grogan, IR Kirsch
Neoplasia (New York, N.Y.) 1999
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways
JR Jass, KG Biden, MC Cummings, LA Simms, M Walsh, E Schoch, SJ Meltzer, C Wright, J Searle, J Young, BA Leggett
Journal of clinical pathology 1999
Mismatch repair and drug responses in cancer
WD Sedwick, SD Markowitz, ML Veigl
Drug Resistance Updates 1999
Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines
WE Glaab, KR Tindall, TR Skopek
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1999
Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis
X Qin, H Zhou, L Liu, SL Gerson
Carcinogenesis 1999
The “Comparative Growth Assay”: Examining the Interplay of Anti-cancer Agents with Cells Carrying Single Gene Alterations
P Hausner, DJ Venzont, L Grogan, IR Kirsch
Neoplasia (New York, N.Y.) 1999
Mismatch repair proficiency and in vitro response to 5-fluorouracil
J M Carethers, D P Chauhan, D Fink, S Nebel, R S Bresalier, S B Howell, C R Boland
Gastroenterology 1999
Mismatch Repair Proficiency and In Vitro Response to 5-Fluorouracil
JOHN M. CARETHERS, DHARAM P. CHAUHAN, DANIEL FINK, SIBYLLE NEBEL, ROBERT S. BRESALIER, STEPHEN B. HOWELL, C. RICHARD BOLAND
Gastroenterology 1999
Broadsheet number 52: molecular genetics of colorectal cancer
JR Jass
Pathology 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin
B Cenni, HK Kim, GJ Bubley, S Aebi, D Fink, BA Teicher, SB Howell, RD Christen
British Journal of Cancer 1999
Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT
X Qin, L Liu, SL Gerson
Oncogene 1999
Mismatch repair, G 2 /M cell cycle arrest and lethality after DNA damage
G Aquilina, M Crescenzi, M Bignami
Carcinogenesis 1999
Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage
M O'Driscoll, S Martinelli, C Ciotta, P Karran
Carcinogenesis 1999
Morphology of sporadic colorectal cancer with DNA replication errors
JR Jass, KA Do, LA Simms, H Iino, C Wynter, SP Pillay, J Searle, G Radford-Smith, J Young, B Leggett
Gut 1998
Complementation of mismatch repair gene defects by chromosome transfer
KR Tindall, WE Glaab, A Umar, JI Risinger, M Koi, JC Barrett, TA Kunkel
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1998
Frequency of HPRT gene mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines
W Zhu, H Yamasaki, N Mironov
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1998
Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate
WE Glaab, JI Risinger, A Umar, JC Barrett, TA Kunkel, KR Tindall
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1998
Genetic Instability and Chromosomal Aberrations in Colorectal Cancer: A Review of the Current Models
C. Richard Boland, Juichi Sato, Koji Saito, John M. Carethers, Giancarlo Marra, Luigi Laghi, Chauhan
Cancer Detection & Prevention 1998
Search for Chromosome Instability in Lymphocytes with Germ-Line Mutations in DNA Mismatch Repair Genes
NM Lindor, SM Jalal, TJ VanDeWalker, JM Cunningham, RJ Dahl, SN Thibodeau
Cancer Genetics and Cytogenetics 1998
Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
GA Macdonald, JK Greenson, K Saito, SP Cherian, HD Appelman, CR Boland
Hepatology 1998
DNA Repair
F Eckstein, DM Lilley
DNA repair 1998
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
S DAtri, L Tentori, PM Lacal, G Graziani, E Pagani, E Benincasa, G Zambruno, E Bonmassar, J Jiricny
Molecular pharmacology 1998
MutS homologs in mammalian cells
R Fishel, T Wilson
Current Opinion in Genetics & Development 1997
DNA mismatch repair in mammals: role in disease and meiosis
N Arnheim, D Shibata
Current Opinion in Genetics & Development 1997
Loss of DNA Mismatch Repair: Effects on the Rate of Mutation to Drug Resistance
MM de las Alas, S Aebi, D Fink, SB Howell, G Los
JNCI Journal of the National Cancer Institute 1997
Breast Cancer
JR Harris, ME Lippman, U Veronesi, W Willett
New England Journal of Medicine 1992

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts